InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ANI PHARMACEUTICALS INC

ANIP Clue Score55
United States Fiscal year ends December CIK 0001023024
$73.89 +2.65% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $73.89 +97.99% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue128.6Operating income20.1Net income3.9EPS, diluted0.34Fiscal year 2017Revenue176.8 +37.5%Operating income28.3Net income−1.1 −127.4%EPS, diluted−0.09 −126.5%Fiscal year 2018Revenue201.6 +14.0%Operating income35.4Net income15.5EPS, diluted1.30Fiscal year 2019Revenue206.5 +2.5%Operating income16.4Net income6.1 −60.7%EPS, diluted0.50 −61.5%Fiscal year 2020Revenue208.5 +0.9%Operating income−16.0Net income−22.5 −470.0%EPS, diluted−1.88 −476.0%Fiscal year 2021Revenue216.1 +3.7%Operating income−39.8Net income−42.6EPS, diluted−3.40Fiscal year 2022Revenue316.4 +46.4%Operating income−35.3Net income−47.9EPS, diluted−3.05Fiscal year 2023Revenue486.8 +53.9%Operating income47.0Net income18.8EPS, diluted0.85Fiscal year 2024Revenue614.4 +26.2%Operating income0.6Net income−18.5 −198.6%EPS, diluted−1.04 −222.4%Fiscal year 2025Revenue883.4 +43.8%Operating income111.1Net income78.3EPS, diluted3.32
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 128.6 176.8 201.6 206.5 208.5 216.1 316.4 486.8 614.4 883.4
Growth +37.5% +14.0% +2.5% +0.9% +3.7% +46.4% +53.9% +26.2% +43.8%
Operating income 20.1 28.3 35.4 16.4 −16.0 −39.8 −35.3 47.0 0.6 111.1
Net income 3.9 −1.1 15.5 6.1 −22.5 −42.6 −47.9 18.8 −18.5 78.3
Growth −127.4% −60.7% −470.0% −198.6%
EPS, diluted 0.34 −0.09 1.30 0.50 −1.88 −3.40 −3.05 0.85 −1.04 3.32
Growth −126.5% −61.5% −476.0% −222.4%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin15.6%Net margin3.1%Free cash flow margin17.8%Fiscal year 2017Operating margin16.0%Net margin−0.6%Free cash flow margin16.4%Fiscal year 2018Operating margin17.5%Net margin7.7%Free cash flow margin30.4%Fiscal year 2019Operating margin7.9%Net margin3.0%Free cash flow margin18.9%Fiscal year 2020Operating margin−7.7%Net margin−10.8%Free cash flow margin4.4%Fiscal year 2021Operating margin−18.4%Net margin−19.7%Free cash flow margin0.4%Fiscal year 2022Operating margin−11.2%Net margin−15.1%Free cash flow margin−12.7%Fiscal year 2023Operating margin9.6%Net margin3.9%Free cash flow margin22.6%Fiscal year 2024Operating margin0.1%Net margin−3.0%Free cash flow margin7.8%Fiscal year 2025Operating margin12.6%Net margin8.9%Free cash flow margin19.4%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin 15.6% 16.0% 17.5% 7.9% −7.7% −18.4% −11.2% 9.6% 0.1% 12.6%
Net margin 3.1% −0.6% 7.7% 3.0% −10.8% −19.7% −15.1% 3.9% −3.0% 8.9%
Free cash flow margin 17.8% 16.4% 30.4% 18.9% 4.4% 0.4% −12.7% 22.6% 7.8% 19.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow27.5Capital expenditure−4.6Free cash flow22.9Buybacks−2.5Fiscal year 2017Operating cash flow39.4Capital expenditure−10.4Free cash flow29.1 +26.8%Buybacks0.0Fiscal year 2018Operating cash flow67.1Capital expenditure−5.7Free cash flow61.3 +111.1%Buybacks0.0Fiscal year 2019Operating cash flow45.6Capital expenditure−6.6Free cash flow39.0 −36.4%Buybacks−1.0Dividends paid0.0Fiscal year 2020Operating cash flow15.3Capital expenditure−6.1Free cash flow9.1 −76.6%Buybacks−1.5Dividends paid0.0Fiscal year 2021Operating cash flow3.3Capital expenditure−2.6Free cash flow0.8 −91.6%Buybacks−0.9Dividends paid−0.2Fiscal year 2022Operating cash flow−31.2Capital expenditure−8.9Free cash flow−40.1 −5,339.1%Buybacks−2.0Dividends paid−1.6Fiscal year 2023Operating cash flow119.0Capital expenditure−8.9Free cash flow110.1Buybacks−5.0Dividends paid−1.6Fiscal year 2024Operating cash flow64.0Capital expenditure−16.2Free cash flow47.8 −56.6%Buybacks−11.0Dividends paid−1.6Fiscal year 2025Operating cash flow185.2Capital expenditure−13.8Free cash flow171.4 +258.7%Buybacks−12.2Dividends paid−1.2
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 27.5 39.4 67.1 45.6 15.3 3.3 −31.2 119.0 64.0 185.2
Capital expenditure −4.6 −10.4 −5.7 −6.6 −6.1 −2.6 −8.9 −8.9 −16.2 −13.8
Free cash flow 22.9 29.1 61.3 39.0 9.1 0.8 −40.1 110.1 47.8 171.4
Growth +26.8% +111.1% −36.4% −76.6% −91.6% −5,339.1% −56.6% +258.7%
Buybacks −2.5 0.0 0.0 −1.0 −1.5 −0.9 −2.0 −5.0 −11.0 −12.2
Dividends paid n/a n/a n/a 0.0 0.0 −0.2 −1.6 −1.6 −1.6 −1.2

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash27.4Total debt0.0Net cash (debt)27.4Shareholders’ equity169.6Debt to equity0.00Fiscal year 2017Cash31.1Total debt73.3Net cash (debt)−42.2Shareholders’ equity174.8Debt to equity0.42Fiscal year 2018Cash43.0Total debt70.6Net cash (debt)−27.5Shareholders’ equity197.3Debt to equity0.36Fiscal year 2019Cash62.3Total debt185.7Net cash (debt)−123.4Shareholders’ equity212.8Debt to equity0.87Fiscal year 2020Cash7.9Total debt185.7Net cash (debt)−177.8Shareholders’ equity195.7Debt to equity0.95Fiscal year 2021Cash100.3Total debt287.4Net cash (debt)−187.1Shareholders’ equity333.9Debt to equity0.86Fiscal year 2022Cash48.2Total debt286.5Net cash (debt)−238.3Shareholders’ equity313.7Debt to equity0.91Fiscal year 2023Cash221.1Total debt285.7Net cash (debt)−64.5Shareholders’ equity432.7Debt to equity0.66Fiscal year 2024Cash144.9Total debt318.3Net cash (debt)−173.4Shareholders’ equity403.7Debt to equity0.79Fiscal year 2025Cash285.6Total debt309.1Net cash (debt)−23.5Shareholders’ equity540.7Debt to equity0.57
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 27.4 31.1 43.0 62.3 7.9 100.3 48.2 221.1 144.9 285.6
Total debt 0.0 73.3 70.6 185.7 185.7 287.4 286.5 285.7 318.3 309.1
Net cash (debt) 27.4 −42.2 −27.5 −123.4 −177.8 −187.1 −238.3 −64.5 −173.4 −23.5
Shareholders’ equity 169.6 174.8 197.3 212.8 195.7 333.9 313.7 432.7 403.7 540.7
Debt to equity 0.00 0.42 0.36 0.87 0.95 0.86 0.91 0.66 0.79 0.57

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
128.6 176.8 201.6 206.5 208.5 216.1 316.4 486.8 614.4 883.4
Growth +37.5% +14.0% +2.5% +0.9% +3.7% +46.4% +53.9% +26.2% +43.8%
48.8 79.0 73.0 63.2 87.2 n/a n/a n/a n/a n/a
2.9 9.1 15.4 19.8 16.0 11.4 22.3 34.3 44.6 51.7
27.8 31.6 44.1 55.8 65.0 84.3 124.0 161.7 249.6 317.7
20.1 28.3 35.4 16.4 −16.0 −39.8 −35.3 47.0 0.6 111.1
Growth +41.1% +24.8% −53.8% −198.0% −98.8% +18,922.8%
8.7 16.3 20.1 3.2 −26.0 −56.1 −62.7 19.9 −22.2 95.8
4.7 17.4 4.6 −2.9 −3.4 −13.5 −14.8 1.1 −3.7 17.5
3.9 −1.1 15.5 6.1 −22.5 −42.6 −47.9 18.8 −18.5 78.3
Growth −127.4% −60.7% −470.0% −198.6%
Per share
0.34 −0.09 1.31 0.51 −1.88 −3.40 −3.05 0.86 −1.04 3.50
0.34 −0.09 1.30 0.50 −1.88 −3.40 −3.05 0.85 −1.04 3.32
Growth −126.5% −61.5% −476.0% −222.4%
11.4 11.5 11.7 11.8 12.0 12.6 16.3 18.0 19.3 20.1
11.6 11.5 11.8 12.0 12.0 12.6 16.3 18.2 19.3 21.2
Growth −0.2% +1.9% +2.3% −0.6% +5.3% +29.1% +11.9% +6.2% +9.9%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 33.5% a year over five years.
  • The diluted share count rose 77.4% in five years, which is dilution.
  • Operating margin is up 20.3 points on five years ago, at 12.6%.
  • A net loss in 5 of 10 years on file.